Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2005;46:562-568
Published online before print August 22, 2005, doi: 10.1161/01.HYP.0000179584.39937.41
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
46/3/562    most recent
01.HYP.0000179584.39937.41v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhao, X.
Right arrow Articles by Inscho, E. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhao, X.
Right arrow Articles by Inscho, E. W.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CALCIUM COMPOUNDS
*CALCIUM, ELEMENTAL
Medline Plus Health Information
*High Blood Pressure
Related Collections
Right arrow Other hypertension
Right arrow Peripheral vascular disease
Right arrow Other Vascular biology

(Hypertension. 2005;46:562.)
© 2005 American Heart Association, Inc.


Original Articles

Impaired Ca2+ Signaling Attenuates P2X Receptor–Mediated Vasoconstriction of Afferent Arterioles in Angiotensin II Hypertension

Xueying Zhao; Anthony K. Cook; Mary Field; Brentan Edwards; Shali Zhang; Zhanying Zhang; Jennifer S. Pollock; John D. Imig; Edward W. Inscho

From the Vascular Biology Center (X.Z., M.F., J.S.P., J.D.I.), Department of Physiology (A.K.C., B.E., S.Z., Z.Z., J.D.I., E.W.I.), and Department of Pharmacology and Toxicology (X.Z., J.S.P.), Medical College of Georgia, Augusta.

Correspondence to Edward W. Inscho, PhD, Department of Physiology, Medical College of Georgia, 1120 15th St, Augusta, GA 30912-3000. E-mail einscho{at}mail.mcg.edu

This study tested the hypothesis that afferent arteriolar responses to purinoceptor activation are attenuated, and Ca2+ signaling mechanisms are responsible for the blunted preglomerular vascular reactivity in angiotensin II (Ang II) hypertension. Experiments determined the effects of ATP, the P2X1 agonist ß,{gamma}–methylene ATP or the P2Y agonist UTP on arteriolar diameter using the juxtamedullary nephron technique and on renal myocyte intracellular Ca2+ concentration ([Ca2+]i) using single cell fluorescence microscopy. Six or 13 days of Ang II infusion significantly attenuated the vasoconstrictor responses to ATP and ß,{gamma}–methylene ATP (P<0.05). During exposure to ATP (1, 10, and 100 µmol/L), afferent diameter declined by 17±2%, 29±3%, and 30±2% in normal control rats and 8±3%, 7±3%, and 22±3% in kidneys of Ang II–infused rats (13 days). Renal myocyte intracellular calcium responses to ATP or ß,{gamma}–methylene ATP were also decreased in Ang II hypertensive rats. In myocytes of control rats, peak increases in [Ca2+]i averaged 107±21, 170±38, and 478±79 nmol/L at ATP concentrations of 1, 10, and 100 µmol/L, respectively. Ang II infusion for 13 days decreased the peak responses to ATP (1, 10, and 100 µmol/L) to 65±13, 102±20, and 367±73 nmol/L, respectively. The peak increases in [Ca2+]i in response to ß,{gamma}–methylene ATP were also reduced in Ang II hypertensive rats. However, angiotensin hypertension did not change the UTP-mediated vasoconstrictor responses or the myocyte calcium responses to UTP. These results indicate that the impaired autoregulatory response observed in Ang II–dependent hypertension can be attributed to impairment of P2X1 receptor–mediated signal transduction.


Key Words: autoregulation • receptors, purinergic • calcium • microcirculation • renal circulation




This article has been cited by other articles:


Home page
HypertensionHome page
Z. Guan, J. S. Pollock, A. K. Cook, J. L. Hobbs, and E. W. Inscho
Effect of Epithelial Sodium Channel Blockade on the Myogenic Response of Rat Juxtamedullary Afferent Arterioles
Hypertension, November 1, 2009; 54(5): 1062 - 1069.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
E. W. Inscho, A. K. Cook, R. C. Webb, and L.-M. Jin
Rho-kinase inhibition reduces pressure-mediated autoregulatory adjustments in afferent arteriolar diameter
Am J Physiol Renal Physiol, March 1, 2009; 296(3): F590 - F597.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
E. W. Inscho
Mysteries of Renal Autoregulation
Hypertension, February 1, 2009; 53(2): 299 - 306.
[Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. Hultstrom, E. Y. Lai, Z. Ma, O. Kallskog, A. Patzak, and A. E. G. Persson
Adenosine triphosphate increases the reactivity of the afferent arteriole to low concentrations of norepinephrine
Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2007; 293(6): R2225 - R2231.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
Z. Guan, D. A. Osmond, and E. W. Inscho
Purinoceptors in the Kidney
Experimental Biology and Medicine, June 1, 2007; 232(6): 715 - 726.
[Abstract] [Full Text] [PDF]